8G19 image
Deposition Date 2023-02-01
Release Date 2023-10-18
Last Version Date 2024-11-06
Entry Detail
PDB ID:
8G19
Keywords:
Title:
Crystal structure of monoreactive 4C05 human Fab
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.77 Å
R-Value Free:
0.21
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Heavy chain of anti-influenza human 4C05 Fab fragment
Chain IDs:B (auth: H)
Chain Length:225
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Light chain of anti-influenza human 4C05 Fab fragment
Chain IDs:A (auth: L)
Chain Length:209
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Biochemical and biophysical characterization of natural polyreactivity in antibodies.
Cell Rep 42 113190 113190 (2023)
PMID: 37804505 DOI: 10.1016/j.celrep.2023.113190

Abstact

To become specialized binders, antibodies undergo a process called affinity maturation to maximize their binding affinity. Despite this process, some antibodies retain low-affinity binding to diverse epitopes in a phenomenon called polyreactivity. Here we seek to understand the molecular basis of this polyreactivity in antibodies. Our results highlight that polyreactive antigen-binding fragments (Fabs) bind their targets with low affinities, comparable to T cell receptor recognition of autologous classical major histocompatibility complex. Extensive mutagenic studies find no singular amino acid residue or biochemical property responsible for polyreactive interaction, suggesting that polyreactive antibodies use multiple strategies for engagement. Finally, our crystal structures and all-atom molecular dynamics simulations of polyreactive Fabs show increased rigidity compared to their monoreactive relatives, forming a neutral and accessible platform for diverse antigens to bind. Together, these data support a cooperative strategy of rigid neutrality in establishing the polyreactive status of an antibody molecule.

Legend

Protein

Chemical

Disease

Primary Citation of related structures